A busy season of NANO2ALL national multi-stakeholder dialogues kicked off on 19 October 2017 with a full-day event at Bloomfield Science Museum Jerusalem, Israel.

These deliberative events aimed to bring together participants from a variety of fields: nanotechnology researchers, research funders, political decision-makers, interest groups, science journalists and citizen representatives. Guided by the results of a previous round of citizen dialogues, 13 Israeli stakeholders engaged with the topic of nanomedicine with great interest and foresight, considering how research and innovation in this growing medical field can better reflect societal values, needs and concerns.

Through interactive group work, open discussions and scenario exploration, participants identified preconditions needed for societal engagement during the development of a nanomedical product. Public exposure, research databanks, open channels that include citizens and patients – these are just a few of their recommendations that were captured by the Responsible Innovation Agenda for Israel (available below).

To find out more, dive into the reports below. Five more multi-stakeholder events have taken place since; find out what stakeholders in France, Italy, Poland, Spain and Sweden had to say.